Works matching IS 00316970 AND DT 2023 AND VI 79 AND IP 9
Results: 14
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022).
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1239, doi. 10.1007/s00228-023-03539-8
- By:
- Publication type:
- Article
Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1271, doi. 10.1007/s00228-023-03538-9
- By:
- Publication type:
- Article
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1229, doi. 10.1007/s00228-023-03536-x
- By:
- Publication type:
- Article
Improved correction formulas to estimate iohexol clearance from simple models.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1215, doi. 10.1007/s00228-023-03535-y
- By:
- Publication type:
- Article
Proton pump inhibitor use: systematic review of global trends and practices.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1159, doi. 10.1007/s00228-023-03534-z
- By:
- Publication type:
- Article
A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1195, doi. 10.1007/s00228-023-03533-0
- By:
- Publication type:
- Article
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations?
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
The effect of perioperative diuretic administration on acute kidney injury in patients with acute myocardial infarction after percutaneous coronary intervention: a real-world retrospective study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1205, doi. 10.1007/s00228-023-03531-2
- By:
- Publication type:
- Article
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1185, doi. 10.1007/s00228-023-03530-3
- By:
- Publication type:
- Article
Medicines postpartum in Sweden and coverage in Janusmed Breastfeeding.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1261, doi. 10.1007/s00228-023-03528-x
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1173, doi. 10.1007/s00228-023-03527-y
- By:
- Publication type:
- Article
Beyond benzodiazepines: a meta-analysis and narrative synthesis of the efficacy and safety of alternative options for alcohol withdrawal syndrome management.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1147, doi. 10.1007/s00228-023-03523-2
- By:
- Publication type:
- Article
The contribution of genotype-guided selection of P2Y<sub>12</sub> inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1249, doi. 10.1007/s00228-023-03519-y
- By:
- Publication type:
- Article
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1219, doi. 10.1007/s00228-023-03514-3
- By:
- Publication type:
- Article